10 Heart Attack Clinical Trials in Omaha, NE (2026)

Q: How do I join a clinical trial in Omaha?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you.

Recruiting Heart Attack Studies in Omaha

NCT07691970Recruiting

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

The purpose of this study is to provide continued access to anifrolumab to eligible participants who are continuing to derive clinical benefit from treatment at the end of a parent clinical study, as ...

Omaha, NEPHASE31,072 participantsAstraZeneca

View Study Details

NCT06876649Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....

Omaha, NEPHASE4787 participantsEli Lilly and Company

View Study Details

NCT07140939Recruiting

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

A phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat....

Omaha, NEPHASE3320 participantsCaliway Biopharmaceuticals Co., Ltd.

View Study Details

NCT06876662Recruiting

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed originator study, clinical study LOXO-BTK-18001/J2N-OX-...

Omaha, NEPHASE4279 participantsEli Lilly and Company

View Study Details

NCT06308978Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants ...

Omaha, NEPHASE1244 participantsFate Therapeutics

View Study Details

NCT04898790Recruiting

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

Cancer and treatment-related cognitive changes, such as thinking or remembering, hinder resumption of normal routine and roles and worsen quality of life. Older adults undergoing hematopoietic cell tr...

Omaha, NENA114 participantsUniversity of Nebraska

View Study Details

NCT03574207Recruiting

Targeted Transcranial Magnetic Stimulation to Improve Hippocampal-dependent Declarative Memory Abilities

This is a pilot study of non-invasive transcranial magnetic stimulation (TMS) to improve memory in healthy adults. It will also examine treating memory deficits in older adults with amnestic mild cogn...

Omaha, NENA80 participantsUniversity of Nebraska

View Study Details

NCT06916806Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

The purpose of this study is to measure the safety, tolerability, PK, and PD of AZD5492 administered subcutaneously in adult participants with SLE or IIM or RA Study details include: • The study dur...

Omaha, NEPHASE172 participantsAstraZeneca

View Study Details

NCT07171255Recruiting

Improving Exercise Adherence With App Technology for At-Risk Adults Living in Rural Kansas and Nebraska

Alzheimer's disease and related dementias are a public health crisis impacting individuals across the world. In the United States, adults living in rural areas face an elevated risk for cognitive impa...

Omaha, NENA54 participantsCreighton University

View Study Details

NCT03104491Recruiting

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

This study has two phases, Phase I and Phase II. The main goal of the Phase I portion of this research study is to see what doses post-transplant inotuzumab ozogamicin can safely be given to subjects ...

Omaha, NEPHASE144 participantsLeland Metheny

View Study Details

About Heart Attack Clinical Trials in Omaha

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 10 heart attack clinical trials recruiting participants in Omaha, NE. These studies are seeking a combined 3,066 participants. Research is being sponsored by AstraZeneca, Eli Lilly and Company, Caliway Biopharmaceuticals Co., Ltd. and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Omaha — FAQ

Are there heart attack clinical trials in Omaha?

Yes, there are 10 heart attack clinical trials currently recruiting in Omaha, NE. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Omaha?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.

Are clinical trials in Omaha free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 10 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated October 16, 2026 from ClinicalTrials.gov